Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-19014-1.pdf
Reference32 articles.
1. van den Bent, M. J. et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31, 344–350 (2013).
2. Cairncross, G. et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31, 337–343 (2013).
3. Wallner, K. E., Galicich, J. H., Krol, G., Arbit, E. & Malkin, M. G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16, 1405–1409 (1989).
4. Gaspar, L. E. et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24, 55–57 (1992).
5. Garden, A. S. et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 20, 99–110 (1991).
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. COMPREHENSIVE REVIEW OF HIGH-GRADE ASTROCYTOMA GRADE III: ANAPLASTIC ASTROCYTOMA – PREVALENCE, PATHOLOGY, TREATMENT, AND RECURRENCE;Proceeding of the Shevchenko Scientific Society. Medical Sciences;2024-06-28
2. IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas;Journal of Neuro-Oncology;2024-06-23
3. Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report;Indian Journal of Radiology and Imaging;2023-12-04
4. Integrative management of anaplastic astrocytoma through a combination of Ayurveda and conventional care: A case report;Journal of Ayurveda and Integrative Medicine;2023-09
5. Sabotaging the protein factory to overcome glioma stem cell resistance;Neuro-Oncology;2023-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3